30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Research / Technology

Studies indicate that joint replacement recipients who take bisphosphonates post-op may be less likely to require revision surgery. Researchers estimate that for every 107 patients taking the bone drug, one revision would be avoided. (British Medical Journal, 12/7/2011)